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Abstract
Shigella flexneri remains a significant human pathogen due to high morbidity among children < 5 years in developing
countries. One of the key features of Shigella infection is the ability of the bacterium to initiate actin tail polymerisation
to disseminate into neighbouring cells. Dynamin II is associated with the old pole of the bacteria that is associated
with F-actin tail formation. Dynamin II inhibition with dynasore as well as siRNA knockdown significantly reduced
Shigella cell to cell spreading in vitro. The ocular mouse Sereny model was used to determine if dynasore could
delay the progression of Shigella infection in vivo. While dynasore did not reduce ocular inflammation, it did provide
significant protection against weight loss. Therefore dynasore's effects in vivo are unlikely to be related to the
inhibition of cell spreading observed in vitro. We found that dynasore decreased S. flexneri-induced HeLa cell death
in vitro which may explain the protective effect observed in vivo. These results suggest the administration of
dynasore or a similar compound during Shigella infection could be a potential intervention strategy to alleviate
disease symptoms.
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Introduction
Shigella flexneri is the etiological agent of bacillary dysentery
(shigellosis). It is transmitted via the faecal-oral route and is a
significant human pathogen due to the high morbidity among
children < 5 years in developing countries. Over a period
between 1990 - 2009, 125 million shigellosis cases were
recorded in Asia, of which ~ 14,000 were fatal [1]. The lack of a
vaccine, an increase in multi-drug resistance and the absence
of suitable small animal model to study the infection contribute
to the persistence of shigellosis [2].
The pathogenic determinants of S. flexneri are mainly
encoded on the large 200 kb virulence plasmid [3]. These
proteins are involved in the type three secretion system
(TTSS), the modulation of host immune responses, and the
mediation of Shigella actin-based motility (ABM). Shigella
bacteria invade the host intestinal epithelium via microfold cells
and induce pyroptosis of the resident macrophages in the
follicle associated epithelium through caspase-1 activation [4].
Caspase-1 activation releases interleukin-1β (IL-1β) and
interleukin-18 (IL-18), resulting in strong inflammatory
responses and magnified innate responses, respectively [5].
After Shigella bacteria are released into the basolateral
compartment, Shigella bacteria invade enterocytes via the
TTSS, followed by lysis of the endocytic vacuole and
replication in the cytoplasm [6,7]. The Shigella IcsA protein
interacts with the host N-WASP (Neural Wiskott-Aldrich
syndrome protein) and Arp2/3 complex to initiate F-actin
nucleation and polymerisation, leading to ABM and intracellular
spreading and subsequently intercellular spreading via
protrusions into adjacent cells. After escaping from the double
membrane vacuole, subsequent cycles of infection are initiated
[8].
Shigella ABM is dependent on both the 120 kDa outer
membrane protein, IcsA (VirG), and the lipopolysaccharide
(LPS) structure [9-11]. IcsA is necessary for pathogenesis as
∆icsA strains have greatly reduced virulence in human
volunteers and in animal infection models [9,12,13]. Smooth
Shigella strains express the complete LPS molecule, i.e. the
lipid A core, core oligosaccharide and O-antigen subunit. In
rough strains the O-antigen subunit is absent due to mutations
in chromosomal genes encoding for LPS synthesis. Rough
strains can invade epithelial cells and initiate ABM but have a
defect in intercellular spreading [14,15].
Polarised colonic epithelium cells, the site of Shigella
infection, are characterised by apical junctional complexes
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(APCs). APCs consist of tight junctions (TJs) and adherens
junctions (AJs) at the most apical end, which are undercoated
with a prominent network of actin-myosin II (actomyosin) ring
[16]. Thus for cell to cell spreading to occur, the tensions of the
actomyosin ring have to be overcome before disruption of the
cellular contacts can take place [17]. Components of the AJs
and TJs such as L-CAM, α-catenin, β-catenin, α-actinin and
vinculin are found at the actin tail of Shigella during protrusion
formation. L-CAM is important in cell to cell spread as it helps
to maintain a tight association between the bacterium and the
membrane of the protrusions [18,19]. Myosin-X is a component
of adherens junctions but are not localised to the Shigella actin
tail. Knockdown of myosin-X resulted in shortened and
thickened protrusion stalks which reduced the bacteria's ability
to form plaques [20]. Shigella invasion and dissemination is
also dependent on ATP release by connexion 26, and formins,
Dia1 and Dia2 [21,22]. Similar to the Arp2/3 complex, formins
initiate de novo actin polymerisation but can also crosslink actin
filaments [23]. Recent report suggests Shigella preferentially
translocate between TJs where three epithelial cells meet, a
process dependent on the TJ protein, tricellulin [24]. Bacteria
engulfment, but not protrusion formation into the neighbouring
cell is triggered by phosphoinositide 3-kinase and is dependent
upon dynamin II, Epsin-1 and clathrin which are essential
components of the clathrin-mediated endocytic pathway
[24,25].
Dynamin II is a 96 kDa protein with an N-terminal guanine
triphosphatase (GTPase), a middle domain, a pleckstrin
homology (PH) domain, a GTPase effector domain (GED) and
a C-terminal proline rich domain (PRD) [26-28]. It is a
cytoplasmic protein but can be membrane bound via
interactions between its PH domain which binds
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and another
region upstream of the PH domain which inserts into the lipid
bilayer [29]. Three members of the family have been identified;
dynamin I (neurons), dynamin II (ubiquitous) and dynamin III
(brain, lung and testis) [30]. Multiple splice variants were also
identified for all three dynamin isoforms [30]. In its native state,
dynamin is a dimer. In the presence of GTP, helical
dimerisation between adjacent dynamin molecules is thought to
drive assembly-stimulated GTPase activity, resulting in
constriction of the neck of clathrin coated vesicles leading to
scission [31-33]. The GTPase activity of dynamin I, dynamin II
and the mitochondrial dynamin, Drp1 are inhibited by dynasore,
a non-competitive reversible inhibitor [34]. Dynasore has also
been shown to have protective effects in various animal models
of non-infectious human diseases [35-37].
We hypothesized that S. flexneri movement from one cell to
the next may depend on various components important for
endocytosis and/or exocytosis. Hence we investigated the role
of dynamin II in S. flexneri cell to cell spread. In this study
dynamin II inhibition with dynasore as well as knockdown with
dynamin II siRNA reduced Shigella plaque formation. We also
investigated if dynamin II is important for Listeria
monocytogenes cell to cell spreading and found that dynamin II
inhibition with dynasore reduced Listeria plaque formation to a
lesser extent. A murine Sereny test was used to determine if
dynasore could prevent Shigella-induced keratoconjuctivitis.
Infected mice treated with the dynasore carrier alone, NMP/
PEG, developed a strong inflammatory response and lost
significant body weight. Conversely infected mice treated with
dynasore lost a significantly smaller portion of body weight but
a strong inflammatory response was still observed. If dynasore
was inhibiting cell to cell spreading, it is expected that the
inflammatory response would be lessened. This prompted us to
investigate the effect of dynasore on S. flexneri-infected HeLa
cells in a cytotoxicity assay. Surprisingly at high dynasore
concentrations (≥ 120 μM), HeLa cell death was significantly
reduced, which may explain the protective effect observed in
vivo.
Materials and Methods
Bacterial strains and growth media
The strains and plasmids used in this study are listed in
Table 1. Escherichia coli K-12 strain DH5α was used for routine
cloning. All bacterial strains were routinely cultured in Luria
Bertani (LB) broth and on LB agar. S. flexneri strains were
grown from a Congo Red positive colony as described
previously [38]. Bacteria were grown in media for 16 h with
aeration, subcultured 1/20 and then grown to mid-exponential
growth phase by incubation with aeration for 1.5 h at 37°C.
Where appropriate, media were supplemented with tetracycline
(4 or 10 μg/mL) or kanamycin (50 μg/mL).
DNA methods
Plasmid pMP7604 confers tetracycline resistant and
expresses mCherry under the control of the tac promoter [39].
mCherry expression was induced with 2 mM IPTG. Strain
MLRM107 was constructed by electroporation of pMP7604 into
Table 1. Bacterial strains and plasmids.
Strain or plasmid Relevant characteristics#
Reference or
source
Plasmid   
pMP7604 Broad host range vector, pME6031[mCherry; TcR] [39]
E. coli K-12   
DH5α F
- φ80lacZΔM15 Δ(lacZYA-
argF)U169 recA1 endA1 Gibco-BRL
 hsdR17(rk
-, mk+) phoAsupE44 thi-1
gyrA96 relA1 λ-  
S. flexneri   
2457T S. flexneri 2a wild type Laboratory collection
MLRM107 2457T [pMP7604; TcR] This study
RMA723 2457T ΔrmlD::KmR [38]
RMA2041 2457T ΔicsA::TetR [38]
RMA2043 RMA2041 ΔrmlD::KmR [38]
RMA2159 Virulence plasmid-cured 2457T Laboratory collection
L. monocytogenes   
DRDC8 Dairy isolate [70]
# TetR, Tetracycline resistant; KmR, Kanamycin resistant
doi: 10.1371/journal.pone.0084975.t001
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2457T and selected with LB agar supplemented with
tetracycline. DNA manipulation, PCR, transformation and
electroporation into S. flexneri were performed as previously
described [40,41].
Chemicals and antibodies
Dynasore (EC-000.2052; Exclusive Chemistry,
D7693-25MG; Sigma-Aldrich, ab120192; Abcam) was
prepared as an 80 mM stock in dimethyl sulfoxide (DMSO)
(D2650; Sigma-Aldrich) for in vitro studies. For in vivo studies,
dynasore was dissolved in a formulation containing 1-methyl-2-
pyrrolidione (NMP/Pharmasolve; Ashland ISP) and
polyethylene glycol 300 (PEG300; Sigma-Aldrich) (1 part NMP
to 9 parts PEG300). Chemicals were prepared as a 22 mg/mL
stock and diluted 1/4 (5.5 mg/mL) with NMP/PEG before
injection into mice. Mouse anti-dynamin antibody (610245; BD
Biosciences) was used at 1:125 for Western immunoblotting.
Rabbit anti-GAPDH antibody (600-401-A33; Rockland
Immunochemicals, Inc.) was used at 1:3000 for Western
immunoblotting. For immunofluorescence (IF) microscopy, the
anti-dynamin antibody, rabbit polyclonal anti-N-WASP [42],
Alexa Fluor 488-conjugated donkey anti-rabbit and Alexa 594-
conjugated donkey anti-mouse secondary antibody (Molecular
Probes) were used at 1:100.
Reverse transfection and HeLa cell lysate preparation
DNMII siRNA (L004007-00-0005) and siRNA controls (Non-
targeting Pool; D-001810-10-05, siGLO Green Transfection
Indicator; D-001630-01-05) were purchased from Thermo
Scientific. siRNAs were transfected with DharmaFECT 3
Transfection Reagent (T-2003-03) and DharmaFECT Cell
Culture Reagent (DCCR; B-004500-100), also purchased from
Thermo Scientific. Reverse transfection of HeLa cells (Human,
cervical, epithelial cells ATCC #CCL-70) were carried out
based on a method by Thermo Scientific. siRNA were prepared
as a 5 µM stock and the final concentration used was 50 nM.
HeLa cells were transfected as follows. 12 µL siRNA, 6 µL
DharmaFect 3 and 282 µL DCCR were mixed and transferred
to a single well in a 12 well tray (Tray 1) and was incubated for
40 min at RT. For each siRNA, two wells were prepared. After
40 min, 2.5 × 105 HeLa cells in 0.9 mL MEM, 10% FCS were
added to each well. The tray was incubated overnight at 37°C,
5% CO2. HeLa cells were re-transfected on day 2. 12 µL
siRNA, 6 µL DharmaFect 3 and 282 µL DCCR were mixed and
transferred to a single well in a 12 well tray (Tray 2) and was
incubated for 40 min at RT. HeLa cells from the one well that
was transfected the day before (Tray 1) were trypsinised (110
µL 0.1% [w/v] trypsin/0.02% [w/v] EDTA/PBS) and
resuspended in 190 µL MEM, 10% FCS. The trypsinised HeLa
cells were combined with 600 µL MEM, 10% FCS and were
added to the DCCR mixture in Tray 2. The tray was incubated
overnight at 37°C, 5% CO2. On day 3, HeLa cell lysate extracts
were prepared as described by Qualmann and Kelly [43] with
some modifications. Re-transfected HeLa monolayers from two
wells of a 12-well tray were washed with PBS for 15 - 20 min,
dislodged with 110 μL trypsin and resuspended in 190 μL PBS.
The cells were pelleted by centrifugation (3,500 rpm, 5 min,
RT, Eppendorf 5415R) and the pellet was resuspended in 80
μL in 0.1 % (v/v) Triton X-100 in lysis buffer A (10 mM HEPES
pH 7.4, 150 mM NaCl, 1 mM EGTA, 0.1 mM MgCl2)
supplemented with protease inhibitors (5 μg/mL pepstatin, 10
μg/mL aprotinin, 10 μg/mL chymostatin, 1 mM PMSF). The
cells were lysed at 4°C for 30 min and were pelleted by
centrifugation (25,000 rpm, 30 min, 4°C, Beckman OptimaTM
MAX-UP Ultracentrifuge). The supernatant was collected and
mixed with 80 μL 2× Sample buffer (0.125 M Tris-HCl, pH 6.8,
4% [w/v] SDS, 20% [v/v] glycerol, 10% [v/v] β-mercaptoethanol,
0.04% [w/v] Bromophenol blue), and stored at -20°C. Samples
were heated at 100°C for 5 min prior to SDS-PAGE.
SDS-PAGE and Western immunoblotting
SDS-PAGE (12% acrylamide gel) and Western
immunoblotting were carried out as described previously [42].
Molecular weight markers used were BenchMark™ Pre-
Stained Protein Ladder (Invitrogen).
Plaque assay
Plaque assays were performed with HeLa cells as described
previously by Oaks et al. [44] with modifications. 1.2 × 106
HeLa cells were seeded in six-well trays in minimal essential
medium (MEM), 10% FCS, 1% penicillin/streptomycin. Cells
were grown to confluence overnight and were washed twice
with Dulbecco’s modified Eagle medium (DMEM) prior to
inoculation. 2.5 × 104 mid-exponential phase bacteria were
added to each well. Trays were incubated at 37°C, 5% CO2
and were rocked gently every 15 min to spread the inoculum
evenly across the well. At 90 min post infection, the inoculum
was aspirated. 3 mL of the first overlay (DMEM, 5% FCS, 20
µg/mL gentamicin, 0.5% (w/v) agarose [Seakem ME]) was
added to each well. Dynasore or DMSO were added and were
swirled to ensure even distribution. The second overlay
(DMEM, 5% FCS, 20 µg/mL gentamicin, 0.5% (w/v) agarose,
0.1% (w/v) Neutral Red solution [Gibco BRL]) was added 48 h
post infection and plaques were imaged 6 h later. All
observable plaques were counted and the diameter was
measured for each condition in each experiment. At least 25
plaques were measured for each condition.
Infection foci assay
HeLa cells were transfected prior to infection foci assay as
per “Reverse transfection”. On day 3, the infection foci assay
was carried out. Transfected HeLa cells were washed twice
with DMEM prior to inoculation. 5 × 104 mid-exponential phase
bacteria expressing mCherry were added to each well. Trays
were incubated at 37°C, 5% CO2 and were rocked every 15
min to spread the inoculum evenly across the well. At 90 min
post infection, the inoculum was aspirated. 1.5 mL of DMEM
(phenol red-free) (31053-028; Life Technologies), 1 mM
sodium pyruvate, 5% FCS, 20 µg/mL gentamicin, 2 mM IPTG
was added to each well. 24 h later the infection foci were
imaged with an Olympus IX-70 microscope using a 10×
objective. The filter set used was DA/FI/TX-3X-A-OMF
(Semrock). Fluorescence and phase contrast images were
captured and false colour merged with the Metamorph software
program (Version 7.7.3.0, Molecular Devices). The area of the
infection foci i.e. area where mCherry was expressed, was
Dynamin II and Shigella
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outlined and measured with Metamorph. All observable
infectious foci were counted and the area was measured for
each condition in each experiment. At least 20 infectious foci
were measured for each condition.
Invasion assay and IF microscopy
HeLa cells (8 × 104) were seeded onto sterile glass cover
slips in 24-well trays in MEM, 10% FCS, 1% penicillin/
streptomycin. For transfected HeLa cells, refer to “Reverse
transfection”. The following modifications were made. On day
1, one well was prepared for each siRNA. On day 2, the
siRNA:DharmaFect3:DCCR mixture was halved. 80% of the
HeLa cells that had been transfected on day 1 were reseeded
in Tray 2. Cells were grown to semi-confluence overnight,
washed twice with Dulbecco’s PBS (D-PBS) and once with
MEM, 10% FCS. 4 x 107 mid-exponential phase bacteria were
added to each well and subsequently centrifuged (2,000 rpm, 7
min, Heraeus Labofuge 400 R) onto HeLa cells. After 1 h
incubation at 37°C, 5% CO2, the infected cells were washed
thrice with D-PBS and incubated with 0.5 mL MEM containing
40 µg/mL of gentamicin for a further 1.5 h. Infected cells were
washed thrice in D-PBS, fixed in 3.7% (v/v) formalin for 15 min,
incubated with 50 mM NH4Cl in D-PBS for 10 min, followed by
permeabilization with 0.1% Triton X-100 (v/v) for 5 min. After
blocking in 10% FCS in PBS, the infected cells were incubated
at 37°C for 30 min with the desired primary antibody. After
washing in PBS, coverslips were incubated with either Alexa
Fluor 594-conjugated donkey anti-rabbit or Alexa 594-
conjugated donkey anti-mouse secondary antibody (Molecular
Probes) (1:100). F-actin was visualised by staining with Alexa
Fluor 488-conjugated phalloidin (2 U/mL) and 4’,6’-diamidino-2-
phenylindole (DAPI) (10 μg/mL) was used to counterstain
bacteria and HeLa cell nuclei. Coverslips were mounted on
glass slides with Mowiol 4-88 (Calbiochem) containing 1 µg/mL
p-phenylenediamine (Sigma) and was imaged using a 100× oil
immersion objective (Olympus IX-70). The filter set used was
DA/FI/TX-3X-A-OMF (Semrock). Fluorescence and phase
contrast images were false colour merged using the
Metamorph software program.
Protrusion formation
HeLa cells were seeded, infected and fixed as per "Invasion
assay and IF microscopy". HeLa cells were washed twice with
1× Annexin V binding buffer (99902; Biotium) prepared in milliQ
(18.2 MΩ·cm) water, mounted on glass slides with the same
buffer and were imaged using a 40× oil immersion objective
(Olympus IX-70). Protrusion formation was defined as any
extensions of bacterial projection(s) (minimum of a full bacterial
length) beyond the periphery of the HeLa cell. For each
condition in each experiment, a minimum of 100 cells were
imaged.
Assay for growth of intracellular bacteria
HeLa cells (8 × 104) were seeded in 24-well trays in MEM,
10% FCS, 1% penicillin/streptomycin. Cells were grown to
semi-confluence overnight, washed twice with Dulbecco’s PBS
(D-PBS) and once with MEM, 10% FCS. 4 × 107 mid-
exponential phase bacteria were added to each well
(multiplicity of infection, MOI ~ 500). The bacteria were
centrifuged (2,000 rpm, 7 min, Heraeus Labofuge 400 R) onto
HeLa cells. After 1 h incubation at 37°C, 5% CO2, the infected
cells were washed thrice with D-PBS and incubated with 0.5
mL MEM containing 40 µg/mL of gentamicin. At the indicated
intervals, monolayers (in duplicate) were washed four times in
D-PBS and were lysed with 0.1% (v/v) Triton X-100 in PBS for
5 min and bacteria were enumerated on tryptic soy agar (TSA;
Gibco) plates.
LDH cytotoxicity assay
HeLa cells (3 × 104) were seeded in 96-well trays in MEM,
10% FCS, 1% penicillin/streptomycin. Cells were grown to
confluence overnight and were washed twice with PBS. 50 μL
phenol-red free DMEM (31053-028; Life Technologies), 1 mM
sodium pyruvate and 3 × 107 mid-exponential phase bacteria
( MOI ~ 1000) in 50 μL PBS or PBS were added into each well,
where appropriate. The bacteria were centrifuged (2,000 rpm, 7
min, Heraeus Labofuge 400 R) onto HeLa cells. After 1 h
incubation at 37°C, 5% CO2, the infected cells were washed
thrice with PBS and incubated with 0.1 mL phenol-red free
MEM, 40 µg/mL of gentamicin for 4 h. LDH activity was
measured with the Cytotoxicity Detection KitPlus as per
manufacturer's instructions (Roche). The percentage of LDH
released was calculated with the following formula:
((experimental LDH release − spontaneous LDH release)/
(maximal LDH - spontaneous LDH release)) × 100.
Ethics statement
The use of animals in this study has been approved by the
University of Adelaide Animal Ethics Committee (Project
number: S-2012-90). All animals used were handled in
compliance with the Australian code of practice for the care
and use of animals for scientific purposes, 7th edition (2004).
Mouse Sereny test
The mouse Sereny test [45] was carried out as follows. Male
Balb/c mice (20-22g) were inoculated with 2.5 × 107 or 5 × 108
CFUs bacteria in 5 μL of bacterial suspension (in PBS) into the
right eye; the left eye served as a diluent control. To ascertain
the impact of dynasore on ocular infection, mice were injected
intraperitoneal (IP) with drug at a dose rate of 30 mg/kg, at t =
-1, +6, +23 and +30 hours with respect to infection at 0 hours.
Keratoconjunctivitis was evaluated at specific time points after
inoculation and scored on a scale ranging from 0 (no infection),
1 (mild keratoconjuctivitis where the eye lid is slightly swollen),
2 (severe keratoconjuctivitis where the eye is half closed) and 3
(fully developed keratoconjunctivitis where the eye is
completely closed).
Ethics concerns regarding the in vivo use of DMSO
prompted us to adopt a different vehicle, NMP/PEG, which is
made up of 1 part 1-methyl-2-pyrrolidione (NMP) and 9 parts
polyethylene glycol 300 (PEG300), for in vivo studies designed
to assess the impact of dynasore in this model. In vitro studies
showed that plaque formation by S. flexneri strain 2457T was
comparable using either diluent (Figures S1A and S1B). A
preliminary mouse study showed that for injections of dynasore
Dynamin II and Shigella
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(Figure S1C) or vehicle (Figure S1D) resulted in comparable
(~5%) weight loss.
Sectioning and H&E staining of mouse eyes and
eyelids
For histopathological observations, the infected and
uninfected eyes (together with eyelids) were removed and fixed
in 4% buffered formaldehyde overnight before embeddeding in
paraffin. Sections were prepared and stained with hematoxylin
plus eosin by the Ophthalmic Research Laboratories, Centre
for Neurological Diseases, Adelaide, Australia.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism 6.
Results are expressed as means ± SEM of data obtained in
independent experiments. Statistical differences between two
groups were determined with a two-tailed unpaired t-test.
Statistical differences between three or more groups were
determined with a one-way ANOVA followed by Tukey's or
Dunnett's multi comparison post hoc test. Statistical
significance was set at p < 0.05.
Results
Dynamin II is important for S. flexneri cell to cell
spreading but not protrusion formation
We investigated if the process of cell to cell spreading was
dependent on dynamin II, a component of endocytosis. The
effects of dynasore, a dynamin II inhibitor, and dynamin II
siRNA on plaque formation by S. flexneri were determined.
HeLa monolayers infected with S. flexneri were treated with
increasing concentrations of dynasore or with the DMSO
vehicle alone. Treatment with 80 µM dynasore reduced plaque
diameter (*p < 0.05) and addition of 120 µM dynasore
abolished plaque formation altogether (Figure 1A - 1C). S.
flexneri entry into HeLa cells and intracellular growth were not
affected (Figures S2 - S3). We also investigated if dynamin II is
important for Listeria cell to cell spreading. HeLa monolayers
infected with Listeria were treated with the DMSO control or
increasing concentrations of dynasore. The plaque diameter of
Listeria-infected HeLa cells treated with 80 and 120 µM
dynasore were significantly reduced (*p < 0.05) (Figure 1A and
1D). No difference in plaque diameter was observed between
80 µM and 120 µM dynasore.
To investigate the effect of dynamin II depletion on S. flexneri
cell to cell spreading, HeLa cells were transfected with dynamin
II siRNA and an infectious foci assay was carried out. Western
immunoblots of HeLa cell lysates two days post siRNA
treatment showed ~95% reduction in dynamin II levels (Figure
2A). S. flexneri formed infectious foci on HeLa cells treated with
dynamin II siRNA with a reduced foci area but not foci counts
when compared to HeLa cells treated with the negative control
siRNA (*p < 0.05) (Figure 2C - 2D). Therefore dynamin II
inhibition with dynasore as well as siRNA knockdown reduced
Shigella cell to cell spreading.
Next we investigated if dynamin II is involved S. flexneri
protrusion formation, which may account for the reduction in
plaque formation. HeLa monolayers infected with S. flexneri
were treated with the DMSO control or 80 μM dynasore and the
percentage of infected cells with one or more bacteria
protrusions were enumerated by counting >100 cells in each
experiment (Figure 3A and 3B). 66.33 ± 1.35% of infected
HeLa cells had one or more protrusions. Protrusion formation
was not affected by the DMSO control (67.42 ± 1.25%) or 80
μM dynasore (63.12 ± 1.43%). It should be noted that while our
assessment of the effect of dynasore on plaque formation used
confluent cells, and its effect on protrusion formation used semi
confluent cells; this approach to study cell to cell spreading has
previously been reported by others [20,22,46-49].
Dynamin II is localised to the F-actin tail and
protrusions of S. flexneri, adjacent to N-WASP
The polarly localised S. flexneri IcsA protein interacts with
host proteins such as N-WASP and Arp2/3 complex to initiate
actin polymerisation to form an actin tail which imparts motility
to the bacteria [50-52]. We investigated dynamin II localisation
in S. flexneri infected HeLa cells by IF microscopy. Dynamin II
was localised to the S. flexneri F-actin tail and/or protrusion
(Figure 4A). F-actin labelling with FITC-phalloidin does not
readily distinguish F-actin tails from protrusion formation as
both architectures appear as long F-actin structures behind one
pole of the bacteria. We observed 109 infected HeLa cells, and
found that 150 out of 158 (95%) of S. flexneri F-actin tails
and/or protrusions were localised with dynamin II. Treatment
with DMSO and 80 µM dynasore did not affect dynamin II
localisation (Figure 4B and 4C). In 104 infected HeLa cells
treated with 80 µM dynasore, 143 out of 154 S. flexneri (93%)
F-actin tails and/or protrusions were localised with dynamin II.
Similarly in 109 infected HeLa cells treated with the DMSO
control, 152 out of 159 S. flexneri (96%) F-actin tails and/or
protrusions were localised with dynamin II. These results
suggest dynamin II interaction at the S. flexneri F-actin tail
and/or protrusion does not require the activity of its GTPase
domain. In dynamin II siRNA transfected cells, a reduction in
cellular dynamin II protein levels was observed, as expected.
Reduction of dynamin II protein level did not affect dynamin II
localisation to the bacteria F-actin tail (Figure 4D).
In R-LPS strains, IcsA polar localisation and ABM is affected
but the bacteria can still invade the cells [53]. The R-LPS strain
can form F-actin tails, albeit infrequently, but these are
shortened and distorted [54]. Similarly S. flexneri icsA mutants
in either the smooth or rough LPS background can invade
HeLa cells. In the R-LPS strain dynamin II is recruited to S.
flexneri F-actin tail (Figure 4E) but no recruitment was
observed for the ∆icsA mutant strains (Figure 4F and 4G). This
suggests that dynamin II may interact with the F-actin tail since
F-actin de novo synthesis is dependent on IcsA. Alternately
dynamin II could also be interacting indirectly with the F-actin
tail through other proteins such as N-WASP which are found at
the S. flexneri bacterial surface [55]. HeLa cells infected with S.
flexneri were labelled with anti-N-WASP and anti-dynamin
(Figure S4). N-WASP is located immediately at the pole of S.
flexneri (Figure S4A), forming a cap. Dynamin II labelling also
resembles a cap at the S. flexneri pole (Figure S4B) and is
Dynamin II and Shigella
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adjacent to the N-WASP cap with a seemingly small area of
overlap (Figure S4C - S4D).
Effect of dynasore on S. flexneri infection of mice
We next investigated the possible in vivo relevance of the
observed association between dynamin II and S. flexneri
Figure 1.  Dynamin II inhibition by dynasore reduces S. flexneri 2457T plaque counts and plaque size.  HeLa cells were
infected with either S. flexneri 2457T or Listeria in a plaque assay using a 6-well tray as described in the Methods. Plaque formation
was performed in the presence of increasing concentrations of dynasore or the vehicle, 0.15% DMSO. (A) Wells were stained with
Neutral Red to makes plaques more visible. Scale bar = 2 mm. (B) The total plaque counts or (C) mean plaque diameters from each
well infected with Shigella were calculated. (D) Mean plaque diameters from each well infected with Listeria were calculated. Data
are represented as mean ± SEM of independent experiments (n = 4 for Shigella and n = 3 for Listeria), analysed with one-way
ANOVA (p < 0.0001), followed by Tukey's post hoc test (*p < 0.05, ****p < 0.0001).
doi: 10.1371/journal.pone.0084975.g001
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Figure 2.  Transfection of HeLa cells with dynamin II siRNA reduces S. flexneri MLRM107 foci counts and foci area.  HeLa
cells were either mock transfected or transfected with control or dynamin II siRNA for 24 h, trypsinised and re-transfected for further
24 h. (A) HeLa cell extracts were probed with anti-dynamin. GAPDH was used as a loading control. (B - D) Post transfection, HeLa
cells were infected with S. flexneri MLRM107 in an infectious foci assay using a 12-well tray as described in the Methods. Infection
foci were imaged 24 h post gentamicin treatment. Images shown are overlay of an image taken with phase contrast and TxRed filter
(10× magnification). The area of the infection foci i.e. area where mCherry was expressed, is outlined. Scale bar = 0.1 mm. (C) The
total foci counts from one well or (D) mean foci area from one well were calculated. Data are represented as mean ± SEM of
independent experiments (n=3). For total foci count analysed with one-way ANOVA, p > 0.05. Mean foci area was analysed with
one-way ANOVA (p = 0.0027), followed by Tukey's post hoc test (*p < 0.05).
doi: 10.1371/journal.pone.0084975.g002
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 spreading. A mouse Sereny test was established and used to
determine whether ocular infection by S. flexneri could be
inhibited by the administration of dynasore. In initial studies,
mice were infected with 5 × 108 CFUs WT S. flexneri 2457T in
the right eye and the left eye was used as the control (Figure
S5A). At 24, 48 and 72 h, scores between 0 and 3 were given
depending on the severity of the inflammation. Histology was
carried out to compare sections prepared from eyes with
scores of 0 (left eye PBS control) and 3 (fully developed
keratoconjuctivitis). No inflammation was observed as
expected in the PBS control (Figure S5B, left image). In the
Shigella infected eye, desquamation and degeneration of the
palpebral conjunctiva and fornix epithelial were observed as
well as infiltration of polymorphonuclear leukocytes into the
epithelial layers (Figure S5B, right image).
Mice were infected with WT, ∆icsA or virulence plasmid
negative (VP¯) S. flexneri strains which are virulent, attenuated
or are completely avirulent, respectively, to establish suitable
controls. Mice infected with the ∆icsA or VP¯ strains did not
develop any observable inflammation (Figure S5C). Mice
infected with WT S. flexneri developed a strong inflammatory
response with a score of ≥ 2.5. The inflammation peaked at 24
and 30 h with four out of six mice developing strong
inflammatory reaction. Over the next two days, the
inflammation slowly resolved with two out of six mice
developing a strong inflammatory response (score of 3) (Figure
Figure 3.  S. flexneri 2457T protrusion is not affected in the presence of dynasore.  HeLa cells were infected with S. flexneri
2457T for 1 h in a 24-well tray. HeLa cells were washed thrice with D-PBS and incubated with MEM containing 40 µg/mL of
gentamicin (t=0) to exclude extracellular bacteria. Concurrently HeLa cells were treated with 80 μM dynasore or DMSO for 1.5 h. At
t = 1.5, HeLa cells were fixed to observe bacteria protrusions. (A) Infected HeLa cells were imaged at 40× magnification. Scale bar =
10 μm. The arrows indicate protrusion formation. Insert shows 2× enlargement of the indicated region. (B) The percentage of
infected cells with bacteria protrusion(s) were enumerated by counting >100 cells in three independent experiments. Data are
represented as mean ± SEM of independent experiments (n = 3), analysed with one-way ANOVA (p > 0.05).
doi: 10.1371/journal.pone.0084975.g003
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Figure 4.  Dynamin II is localised to the S. flexneri 2457T F-actin tails and protrusions.  HeLa cells were infected with S.
flexneri 2457T in an invasion assay as described in the Methods. Bacteria and HeLa nuclei were stained with DAPI (blue), F-actin
was stained with FITC-phalloidin (green) and dynamin II was stained with anti-dynamin and Alexa Fluor 594-conjugated secondary
antibody (red). Images were taken at 100× magnification. Scale bar = 10 μm. (A) – (D) HeLa cells were treated with DMSO,
dynasore or were transfected with dynamin II siRNA and were infected with S. flexneri 2457T; (A) Untreated; (B) 1% DMSO; (C) 80
μM dynasore; (D) Dynamin II siRNA transfected HeLa cells. (E) – (G) HeLa cells were infected and treated as above with S. flexneri
control stains; (E) RMA723 (R-LPS - ∆rmlD); (F) RMA2041 (∆icsA); (G) RMA2043 (∆icsA ∆rmlD). The arrows indicate dynamin II
localisation at comet tails or protrusions. Insert shows 2× enlargement of the indicated region. The experiment was repeated twice
and representative images are shown.
doi: 10.1371/journal.pone.0084975.g004
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S5D). Mice were also weighed on D0 and D3 of the
experiment. Mice infected with the avirulent VP¯ strain did not
lose weight, however mice infected with either WT or ∆icsA
strains had comparable weight loss (~ 6-9%) (Figure S5E).
In the first in vivo study with dynasore, mice were infected
with 5 × 108 CFUs S. flexneri 2457T in the right eye (t = 0) and
were injected IP with dynasore (30 mg/kg) or vehicle at t = -1,
6, 23 and 30 h. The mice in both groups developed ocular
inflammation at a similar rate and the Sereny scores were
similar (Figure 5A and 5B). Mice in both groups also had ruffled
fur and were often reluctant to move, suggesting that the
combination of Shigella infection and injection of NMP/PEG
(alone or in combination with dynasore) was detrimental to the
mice. Mice injected with NMP/PEG lost 15% of their weight
during the course of the infection, which was significantly
higher than that observed in infected mice not receiving
injections (Figure S5E) or in uninfected mice injected with the
vehicle or dynasore (Figures S1C and S1D). Mice injected with
vehicle only also lost more weight (14.49 ± 1.63%) compared
to mice injected with dynasore (8.29 ± 2.01%) (*p < 0.05)
(Figure 5C).
The experiment was repeated with a second group of mice
since the first group had varied Sereny scores at respective
time points. Mice were infected with 5 × 108 CFUs S. flexneri
2457T in the right eye (t = 0) and were IP injected with
dynasore (30 mg/kg) or the vehicle at t = -1, 6, 23 and 30 h and
Figure 5.  Dynasore protects mice against weight loss resulting from S. flexneri 2457T ocular infection (Experiment 1).  (A)
Sereny scores of mice infected with 5 × 108 CFUs S. flexneri 2457T at t = 0 and IP injected with either 100 μL of 5.5 mg/mL of
dynasore in NMP/PEG (30mg/kg) or 100 μL NMP/PEG at t = -1, 7, 23, 30 h post inoculation. Each symbol represents one or more
mice. (B) The total number of mice with a Sereny score of ≥ 2.5 was calculated and plotted as a bar graph for each time point.
Arrows indicate injection with dynasore or NMP/PEG alone. (C) The percentage weight loss for each mouse on D3 was calculated.
Data are represented as mean ± SEM (Student's t-test, *p < 0.05).
doi: 10.1371/journal.pone.0084975.g005
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were weighed daily. Mice developed the ocular inflammation at
the same rate and there was no difference in Sereny scores
(Figure 6A and 6B). Mice injected with dynasore lost
significantly less weight compared to mice treated with the
vehicle alone on D1 (4.39 ± 0.76% vs. 8.77 ± 0.71%, **p <
0.01) and D2 (7.71 ± 1.21% vs. 12.52 ± 1.53%, *p < 0.05)
(Figure 6C). Weight loss which was previously observed on D3
in the first experiment (Figure 5C) was not observed in the
second group of mice. The latter group of mice collectively had
less variations in their Sereny scores (Figure 6A), which could
explain why the weight differences were only observed on D1
and D2. Nonetheless these studies suggest that dynasore
provided a protective effect against weight loss associated with
S. flexneri infection.
Effect of dynasore on mice infected with a low
inoculum of S. flexneri 2457T
Since dynasore treatment reduced weight loss associated
with Shigella infection but not the extent of ocular inflammation,
further studies were performed using a reduced Shigella dose.
Mice were infected with 2.5 × 107 CFUs S. flexneri 2457T and
were weighed on D0 and D3. The mice developed
inflammation at a slightly slower rate compared to the higher
Shigella dose (Figures S5C and S5D); the inflammation
peaked at 54 h with three out of six mice developing an
Figure 6.  Dynasore protects mice against weight loss resulting from S. flexneri 2457T ocular infection (Experiment 2).  (A)
Sereny scores of mice infected with 5 × 108 CFUs S. flexneri 2457T at t = 0 and IP injected with either 100 μL of 5.5 mg/mL of
dynasore in NMP/PEG (30mg/kg) or 100 μL NMP/PEG at t = -1, 7, 23, 30 h post inoculation. Each symbol represents one or more
mice. (B) The total number of mice with a Sereny score of ≥ 2.5 was calculated and plotted as a bar graph for each time point.
Arrows indicate injection with dynasore or NMP/PEG alone. (C) The percentage weight loss for each mouse on D1, D2 and D3 were
calculated. Data are represented as mean ± SEM (Student's t-test, *p < 0.05, **p < 0.01).
doi: 10.1371/journal.pone.0084975.g006
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inflammation with a score of ≥ 2.5 (Figure 7A and 7B). The
mice lost an average of 4% of their body weight (Figure 7C).
In a second study with the same lower challenge dose, mice
were given injection of dynasore (30 mg/kg) or vehicle at t = -1,
6, 23 and 30 h. Mice in both groups developed ocular
inflammation at a similar rate and no difference in Sereny
scores was observed (Figure 7D and 7E). Similar to the high
dose infection, dynasore significantly protected mice against
weight loss associated with Shigella infection when compared
to the vehicle group on D1 (4.81 ± 1.68% vs. 8.75 ± 0.55%, *p
< 0.05) and D2 (6.85 ± 1.82% vs. 12.46 ± 0.67%, *p < 0.05)
(Figure 7F). The group of mice in this study had ruffled fur and
displayed reduced mobility similar to the mice in the higher
challenge dose which were give dynasore or vehicle injection.
In the ocular infection model, dynasore afforded significant
protection against weight loss but did not reduce ocular
inflammation. In contrast, mice infected with ∆icsA (RMA2041)
had similar weight loss to 2457T but no ocular inflammation
was observed (Figure S5C - S5E), suggesting that dynasore is
not preventing S. flexneri cell to cell spreading in vivo.
Effect of dynasore on S. flexneri-induced HeLa cell
death
Since dynasore did not seem to affect S. flexneri cell to cell
spreading and ameliorate inflammation in vivo, we sought to
determine if dynasore could be targeting TTSS effectors
encoded on the VP [56], thus reducing the cytotoxic effects of
the TTSS effectors, using an in vitro cytotoxicity assay.
Previously IpaB and MxiA, both TTSS effectors, have been
reported to play a role in weight loss during S. flexneri infection
[56,57]. HeLa cells were infected with WT, ∆icsA or VP¯ S.
flexneri strains and LDH release was measured (Figure S6).
HeLa cells infected with the VP¯ had very little cell death (2.34
± 0.53%), comparable to the uninfected HeLa cells (5.78 ±
2.99%). In contrast, HeLa cells infected with WT and ∆icsA
strains had 40.2 ± 2.37% and 42.04 ± 2.79% cell death,
respectively. Therefore in the absence of icsA, the bacteria still
retained significant cytotoxicity presumable due the presence
of TTSS effectors encoded by the VP. The weight loss
observed mice infected with the ∆icsA strain in this study
(Figure S5) could be partly attributed to the cytotoxicity from
the TTSS effectors.
Next we treated HeLa cells with increasing concentrations of
dynasore or with the DMSO vehicle alone (Figure 8). No
differences in LDH release was observed between dynasore
and DMSO in uninfected HeLa cells. S. flexneri-induced HeLa
cytotoxicity was significantly reduced in the presence of 120
μM (28.72 ± 4.30%) and 160 μM dynasore (26.1 ± 3.63%)
compared to DMSO-treated cells (47.73 ± 2.84%, *p < 0.05),
suggesting dynasore reduces S. flexneri induced cytotoxicity in
vitro and may explain the weight loss protection observed in
vivo.
Discussion
Shigella infection remains a significant problem in developing
countries. In this study we have identified a potential
intervention strategy by targeting dynamin II, a key component
of the clathrin mediated pathway. Previously dynamin II was
shown to be important for Shigella engulfment, but not
protrusion into the neighbouring cell [24]. In this study the role
of dynamin II in facilitating Shigella cell spreading was explored
with a well described dynamin II inhibitor, dynasore, as well as
by siRNA knockdown.
Inhibition of the dynamin II GTPase activity with dynasore as
well as depletion of dynamin II with siRNA knockdown
significantly reduced S. flexneri plaque size. A reduction in
plaque formation could be attributed to a lack of protrusion
formation. However S. flexneri protrusion formation was not
affected by dynasore, which suggests that dynamin II and
hence endocytosis is critical for S. flexneri entry into
neighbouring cell and not exit from the initially infected cell.
These results are in agreement with recently reported
findings by Fukumatsu et al. [24], where the involvement of
dynamin II, as well components of the of the clathrin-mediated
endocytic pathway have been shown to be important for S.
flexneri cell spreading and pseudopodia formation. Dynamin II
was also reported to accumulate around bacteria containing
pseudopodia [24].
Inhibition of dynasore reduced Listeria plaque formation to a
lesser extent since plaque formation was still observed when
HeLa cells were treated with 120 μM dynasore. At the same
dynasore concentration, plaque formation by Shigella was
abolished. These results suggest Listeria relies less on
dynamin II during cell to cell spreading. Previously dynamin II
had been shown to associate with the Listeria comet tail,
although the role of the protein was not explored [58]. Recently
Fukumatsu et. al. reported that clathrin-mediated endocytosis
is not the primary pathway utilised by Listeria during cell to cell
spreading [24]. Since dynamin II is a critical component of
clathrin-mediated endocytosis, dynamin II may localise non-
specifically to the Listeria F-actin tail or have other unexplored
functions.
S. flexneri cell to cell spreading is dependent on the
bacteria's IcsA protein, a polarly localised outer membrane
protein. IcsA is predominantly expressed on the old pole, i.e.
the pole that was present before cellular division which gives
rise to new daughter poles [50]. IcsA interacts with host
proteins such as N-WASP, which recruits the Arp2/3 complex
to initiate F-actin polymerisation, allowing the bacteria to
spread intracellularly and between cell to cell [50-52]. In the
absence of IcsA, F-actin tails and subsequent protrusion
formation is abolished. The lack of dynamin II recruitment to
the ∆icsA mutants suggests that dynamin II associates with the
F-actin tail as reported for Listeria [58]. The lack of dynamin II
involvement in protrusion formation however, also suggests
that its interaction with F-actin tail could be non-specific. Actin
binding proteins such as Nck has been shown to associate
non-specifically with the S. flexneri F-actin tail [59]. Alternately
dynamin II could play a minor role in membrane remodelling.
BAR domain proteins, such as syndapin and sorting nexin 9
(SNX9), interact with N-WASP and dynamin [43,60]. Double
labelling with anti-N-WASP and anti-dynamin revealed that
dynamin II is localised adjacent to N-WASP at the S. flexneri
old pole. Some overlap of N-WASP and dynamin II labelling
was observed.
Dynamin II and Shigella
PLOS ONE | www.plosone.org 12 December 2013 | Volume 8 | Issue 12 | e84975
Figure 7.  Dynasore protects mice against weight loss from S. flexneri 2457T ocular infection (reduced bacterial
challenge).  (A) Sereny scores of mice infected with 2.5 × 107 CFUs S. flexneri 2457T from 0 - 71 h post inoculation. Each symbol
represents one or more mice. (B) The total number of mice with a Sereny score of ≥ 2.5 was calculated and plotted as a bar graph
for each time point. (C) The percentage weight loss for each mouse on D3 was calculated. (D) Sereny scores of mice infected with
2.5 × 107 CFUs S. flexneri 2457T at t = 0 and IP injected with either 100 μL of 5.5 mg/mL of dynasore in NMP/PEG (30mg/kg) or
100 μL NMP/PEG at t = -1, 7, 23, 30 h post inoculation. Each symbol represents at least one mouse. (E) The total number of mice
with a Sereny score of ≥ 2.5 was calculated and plotted as a bar graph for each time point. Arrows indicate injection with dynasore
or NMP/PEG alone. (F) The percentage weight loss for each mouse on D1, D2 and D3 were calculated. Data are represented as
mean ± SEM (Student's t-test, *p < 0.05).
doi: 10.1371/journal.pone.0084975.g007
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Mice were initially with challenged the WT, ∆icsA and VP¯ S.
flexneri strains to establish suitable controls. IcsA is important
for Shigella cell spreading and absence of the protein
prevented the bacteria from disseminating further as no
inflammation was observed. However, the ∆icsA strain can still
invade the epithelial cells and have TTSS proteins encoded on
the VP such as OspG that can interfere with the host signaling
pathways to prevent clearance of the bacteria [61]. Previously it
was reported that Balb/c mice inoculated intranasally with 2 ×
107 and 2 × 108 CFUs ∆icsA (∆virG) mutant lost >20% of their
body weight 5 days post inoculation [57]. Similarly, we found
that the ∆icsA strain still retained significant virulence as
measured by weight loss in the ocular infection model used in
this study. In a rectal model, guinea pigs inoculated with 1 ×
109 CFUs S. flexneri 2a (strain 2457T and YSH6000) and S.
flexneri 5a (M90T) lost ~20% of their body weight. No weight
loss was observed in guinea pigs inoculated with 2457T VP¯
strain [62]. It was also reported that piglets that were orally
challenged with 5 × 109 CFUs S. dysenteriae type 1 expressing
the Shiga toxin lost considerable amount of weight. Weight lost
was not observed in piglets inoculated with the attenuated
Shiga toxin negative strain [63]. Weight loss during S. flexneri
2a infection has also been reported in other animal models of
infection [64-66].
Mice were challenged with low and high doses of S. flexneri
2457T and treated with dynasore to determine if this drug could
delay the progression of Shigella infection in vivo. Mice infected
with the low dose S. flexneri lost less weight compared to mice
Figure 8.  Dynasore reduces HeLa cell death during S.
flexneri 2457T infection.  HeLa cells were infected with S.
flexneri 2457T in a 96-well tray as described in the Methods.
LDH release was measured in the presence of dynasore or
DMSO. Data are represented as mean ± SEM of independent
experiments (n = 3), analysed with one-way ANOVA (p =
0.0043), followed by Tukey's post hoc test (*p < 0.05). No
differences in LDH release were observed in the presence of
dynasore or DMSO in the absence of bacterial infection.
doi: 10.1371/journal.pone.0084975.g008
infected with the high bacterial dose. Dynasore afforded
significant protection against weight loss for both challenge
doses but did not reduce ocular inflammation. In comparison,
mice infected with ∆icsA (RMA2041) had similar weight loss to
2457T but no ocular inflammation was observed. Hence weight
loss during S. flexneri infection is unrelated to cell to cell
spreading. The in vivo data from this study is summarised in
Table 2.
We investigated if dynasore could be targeting or inhibiting
TTSS effectors encoded on the VP. Addition of 120 μM
dynasore reduced S. flexneri-induced HeLa cell death by ~39%
compared to DMSO-treated cells. The ∆icsA mutant strain
exhibited similar cytotoxicity to the WT strain, suggesting the
HeLa cell death observed is not due to cell to cell spreading.
Dynasore's ability to reduced S. flexneri-induced HeLa
cytotoxicity in vitro could explain the reduction in weight loss in
mice, even though ocular inflammation was not decreased.
Previously Balb/c mice inoculated intranasally with 2 × 108
CFUs ∆ipaB mutant had comparable body weight compared to
saline-treated mice. Furthermore the ∆ipaB mutant had no
cytotoxic effects, as measured by LDH release in mouse J774
macrophages [57]. IpaB (Invasion plasmid antigen B) is a
secreted TTSS protein and has recently been shown to induce
cell death of macrophages by disrupting ion homeostasis within
endosomal compartments leading to subsequent Caspase-1
activated cell death (pyroptosis) [67]. In a recent report adult
B6 mice infected with S. flexneri YSH6000 lost 25% of their
body weight 72 hours after initial infection. Mice infected with a
mxiA::Tn5 insertion mutant (strain S325) did not have any
appreciable weight loss [64]. MxiA is a key structural protein of
the TTSS and mxiA mutants are avirulent [64,68].
Limitations in this study include the dosage of dynasore and
the drug carrier used. In the in vivo experiments mice were
given four dynasore injections during the course of infection. It
is possible that the drug did not reach an effective
concentration in vivo. The NMP/PEG carrier did not result in
significant toxicity alone but the combination of NMP/PEG and
the Shigella infection was detrimental to the mice. This limited
the number of dynasore injections that could be administered
Table 2. Summary of Sereny test. Mice were inoculated
with 5 × 108 CFUs bacteria where applicable.
Strain / treatment Sereny scoreaMean (SD) % weight lossbFigure
WT (2457T) 0.25 - 3 (D3) 6.00 (2.52) (n = 6) S5
∆icsA (RMA2041) 0 (D3) 8.88 (6.37) (n= 4) S5
VP- (RMA2159) 0 (D3) -0.35 (1.93) (n = 4) S5
NMP/PEG (no infection) N/A (D3) 6.29 (0.68) (n = 6) S1
NMP/PEG + Dynasore (no
infection) N/A (D3) 4.44 (3.44) (n = 6) S1
2457T + NMP/PEG (Expt 2) 2.5 - 3 (D2) 12.52 (4.04) (n = 7) 6
2457T + NMP/PEG +
Dynasore (Expt 2) 3 (D2) 7.72 (3.21) (n = 7) 6
a Sereny scores are between 0 - 3, recorded on D2 or D3
b % Mean weight loss on D2 or D3 (see Sereny scores) compared to D0
N/A Not applicable
doi: 10.1371/journal.pone.0084975.t002
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during the infection. Nonetheless these results suggest that
dynamin II inhibition may be a novel intervention strategy for
preventing Shigella dissemination. The use of a different carrier
solvent, increased or prolonged dynasore dosage and a
different administration route may improve the efficacy of
dynasore. Dynasore also inhibits the GTPase activity of Drp1
(Dynamin-related protein 1), a mitochondrial dynamin, which
regulates mitochondrial fission [34,69]. Since dynasore inhibits
both dynamin II and Drp1, a role for dynasore inhibition Drp1 in
preventing weight loss in mice during S. flexneri infection
cannot be ruled out. We are currently investigating this
possibility.
In conclusion, dynamin II is a critical component of Shigella
cell to cell spreading. Our data suggest that the process of
Shigella cell to cell spreading relies in part on components
important for endocytosis. Furthermore dynamin II inhibition
with dynasore or a similar compound could provide a potential
intervention strategy to dampen Shigella dissemination. The
effect of dynasore on TTSS-induced cell death is currently
being investigated.
Supporting Information
Figure S1.  1:9 NMP/PEG as a vehicle for dynasore. (A - B)
HeLa cells were infected with S. flexneri 2457T in a plaque
assay using a 6-well tray as described in the Methods. Plaque
formation was performed in the presence of dynasore
dissolved in either DMSO or NMP/PEG. (A) The total plaque
counts or (B) mean plaque diameters from each well from
independent experiments were calculated. Data are
represented as mean ± SEM of independent experiments (n =
3), analysed with one-way ANOVA (p < 0.0001), followed by
Tukey's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p
< 0.0001). (C - D) Mice were not adversely affected by IP
injection with either 100 μL NMP/PEG or 100 μL 5.5 mg/mL of
dynasore in NMP/PEG (30mg/kg) at t = 0, 7, 24, 31 h in the
absence of bacterial inoculation. Each symbol represents one
mouse. Data are represented as mean ± SEM, analysed with
one-way ANOVA (p = 0.0241 for NMP/PEG and p = 0.4529 for
dynasore in NMP/PEG). Tukey's post hoc test was carried out
for NMP/PEG (*p < 0.05).
(TIF)
Figure S2.  Intracellular growth of S. flexneri 2457T in HeLa
cells is not affected by dynasore. HeLa cells were infected
with S. flexneri 2457T for 1 h in a 24-well tray. HeLa cells were
washed thrice with D-PBS and incubated with MEM containing
40 µg/mL of gentamicin (t=0) to exclude extracellular bacteria.
Concurrently HeLa cells were treated with 80 μM dynasore or
DMSO. For each condition, two wells were prepared for each
time point (t =1, 2, 4 and 6 h). At each interval, HeLa cells were
washed, followed by lysis with 0.1% Triton-X 100 to recover
intracellular bacteria. Data are represented as mean from three
independent experiments.
(TIF)
Figure S3.  S. flexneri 2457T entry into HeLa cells is not
affected by dynasore. HeLa cells were infected with S.
flexneri 2457T for 1 h in a 24-well tray. Concurrently HeLa cells
were treated with 80 μM dynasore or DMSO. For each
condition, two wells were prepared. After the 1 h invasion,
HeLa cells were washed thrice with D-PBS and incubated with
MEM containing 40 µg/mL of gentamicin to exclude
extracellular bacteria. After 2 h, HeLa cells were washed,
followed by lysis with 0.1% Triton-X 100 to recover intracellular
bacteria. Data are represented as mean from three
independent experiments.
(TIF)
Figure S4.  Dynamin II is localised adjacent to N-WASP at
S. flexneri 2457T pole. HeLa cells were infected with S.
flexneri 2457T in an invasion assay as described in the
Methods. Bacteria and HeLa nuclei were stained with DAPI
(blue), N-WASP was stained with anti-N-WASP and Alexa
Fluor 488-conjugated secondary antibody (green); and
dynamin II was stained with anti-dynamin and Alexa Fluor 594-
conjugated secondary antibody (red). Images were taken at
100× magnification. Scale bar = 10 μm. (A) – (C) The white
arrows indicate protrusions. Insert shows 2× enlargement of
the indicated region. Bacteria are outlined with white dotted
lines. (D) The bacteria indicated with the white arrow are
enlarged 6×. The thin arrowhead points to N-WASP and the
thick arrowhead points to dynamin II. The yellow arrows point
to areas of N-WASP and dynamin II overlap. The experiment
was repeated twice and representative images are shown.
(TIF)
Figure S5.  Establishment of a mouse Sereny test to
measure keratoconjuctivitis caused by S. flexneri 2457T.
(A) The left eye was inoculated with LB broth (control) and the
right eye was inoculated with 5 × 108 CFUs WT S. flexneri
2457T. Mouse keratoconjuctival inflammation was defined as
follows: a score of 1 is defined as mild keratoconjuctivitis where
the eye lid is slightly swollen; a score of 2 is defined as severe
keratoconjuctivitis where the eye is half closed and a score of 3
is defined as fully developed keratoconjunctivitis where the eye
is completely closed. (B) Histology of fornix (F), palpebral
conjunctiva (C) and cornea (Cor) of the control eye (left - LB)
and S. flexneri infected eye with a Sereny score of 3 (right -
2457T). Polymorphonuclear leukocytes are infiltrating into the
epithelial layer of the fornix (◄) and submucosal area of the
conjuctiva and cornea (←) (60× magnification). (C-E) Mouse
Sereny test with 5 × 108 CFUs S. flexneri 2457T, ∆icsA
(RMA2041) and virulence plasmid negative strain (VP¯)
(RMA2159). (C) Sereny scores of mice infected with S. flexneri
2457T, RMA2041 and RMA2159 from 0 - 71 h post infection.
Each symbol represents one mouse. (D) The total number of
mice with a Sereny score of ≥ 2.5 was calculated and plotted
as a bar graph for each time point. (E) The percentage weight
loss for each mouse on D3 was calculated. Data are
represented as mean ± SEM, analysed with one-way ANOVA
(p = 0.0171), followed by Dunnett's post hoc test with
comparison to the mean of the VP¯ strain (*p < 0.05).
(TIF)
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Figure S6.  HeLa cell death during S. flexneri 2457T and
∆icsA infection. HeLa cells were infected with S. flexneri
2457T, ∆icsA (RMA2041) and virulence plasmid negative strain
(VP¯) (RMA2159) in a 96-well tray and LDH release was
measured as described in the Methods. Data are represented
as mean ± SEM of independent experiments (n = 3), analysed
with one-way ANOVA (p < 0.0001), followed by Tukey's post
hoc test (****p < 0.0001).
(TIF)
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